Cefiderocol either in monotherapy or combination versus best available therapy in the treatment of carbapenem-resistant Acinetobacter baumannii infections: A systematic review and meta-analysis | Synapse
February 6, 2024Open Access
Cefiderocol either in monotherapy or combination versus best available therapy in the treatment of carbapenem-resistant Acinetobacter baumannii infections: A systematic review and meta-analysis
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Our data strengthen the efficacy and safety profile of cefiderocol in CRAB infections.